Real-world therapeutic maintenance, effectiveness and safety of Janus kinase inhibitors in rheumatoid arthritis before and after PRAC recommendations

tofacitinib - Generic mfg.

Jyseleca (filgotinib) - Gilead

Rinvoq (upadacitinib) - AbbVie

Olumiant (baricitinib) - Eli Lilly

https://distribution-congress.eular.org/from.storage?image=15rRXWmdOAJ77zPlkD-rQv35TqUsFGlQLmbhm-uwgGqtEth-Zj4CM8YHB_kLT8CO0

Salomé Abdellaoui1; Omar Al Tabaa2; Stéphane Hilliquin1; Roberto D'Alessandro1; Sophie Hecquet1; Marion Thomas 1; Sandrine Carvès1; Alice Combier1; Yannick Allanore1; Jerome Avouac1

May 23, 2026